Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 13 locations, and the revision has been updated from v2.9.7 to v2.10.0.
    Difference
    0.5%
    Check dated 2024-07-23T14:46:51.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.9%
    Check dated 2024-07-16T08:31:31.000Z thumbnail image
  7. Check
    14 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-07-13T04:01:57.000Z thumbnail image
  8. Check
    17 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-07-10T00:43:15.000Z thumbnail image
  9. Check
    18 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-07-08T23:09:15.000Z thumbnail image
  10. Check
    24 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 'Acute Graft Versus Host Disease Myeloid Leukemia Acute Non Lymphoblastic Leukemia' to 'Myeloid Leukemia Acute Non Lymphoblastic Leukemia Acute Graft Versus Host Disease'. This change represents a reversal in the order of the conditions listed.
    Difference
    1.0%
    Check dated 2024-07-03T15:31:33.000Z thumbnail image

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.